DE3273893D1 - Pyridazine derivatives active on the central nerve system - Google Patents

Pyridazine derivatives active on the central nerve system

Info

Publication number
DE3273893D1
DE3273893D1 DE8282401426T DE3273893T DE3273893D1 DE 3273893 D1 DE3273893 D1 DE 3273893D1 DE 8282401426 T DE8282401426 T DE 8282401426T DE 3273893 T DE3273893 T DE 3273893T DE 3273893 D1 DE3273893 D1 DE 3273893D1
Authority
DE
Germany
Prior art keywords
central nerve
nerve system
pyridazine derivatives
derivatives active
active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8282401426T
Other languages
German (de)
English (en)
Inventor
Jean-Pierre Chambon
Camille Wermuth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SA filed Critical Sanofi SA
Application granted granted Critical
Publication of DE3273893D1 publication Critical patent/DE3273893D1/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C07D237/34—Phthalazines with nitrogen atoms directly attached to carbon atoms of the nitrogen-containing ring, e.g. hydrazine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20—Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DE8282401426T 1981-08-11 1982-07-30 Pyridazine derivatives active on the central nerve system Expired DE3273893D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8115546A FR2511366A1 (fr) 1981-08-11 1981-08-11 Nouveaux derives de la pyridazine, leur procede de preparation et les medicaments, actifs sur le systeme nerveux central, qui en contiennent

Publications (1)

Publication Number Publication Date
DE3273893D1 true DE3273893D1 (en) 1986-11-27

Family

ID=9261385

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8282401426T Expired DE3273893D1 (en) 1981-08-11 1982-07-30 Pyridazine derivatives active on the central nerve system

Country Status (30)

Country Link
US (1) US4710499A (enExample)
EP (1) EP0073161B1 (enExample)
JP (1) JPS5838263A (enExample)
KR (1) KR880002711B1 (enExample)
AR (1) AR231537A1 (enExample)
AT (1) ATE23042T1 (enExample)
AU (1) AU579570B2 (enExample)
CA (1) CA1179347A (enExample)
CS (1) CS239929B2 (enExample)
DD (1) DD202550A5 (enExample)
DE (1) DE3273893D1 (enExample)
DK (1) DK148596C (enExample)
EG (1) EG15749A (enExample)
ES (1) ES514887A0 (enExample)
FI (1) FI72970C (enExample)
FR (1) FR2511366A1 (enExample)
GR (1) GR76236B (enExample)
HU (1) HU189608B (enExample)
IE (1) IE53493B1 (enExample)
IL (1) IL66424A (enExample)
MA (1) MA19559A1 (enExample)
NO (1) NO158871C (enExample)
NZ (1) NZ201553A (enExample)
OA (1) OA07179A (enExample)
PH (1) PH18921A (enExample)
PL (1) PL137200B1 (enExample)
PT (1) PT75372B (enExample)
SU (1) SU1356960A3 (enExample)
YU (1) YU171682A (enExample)
ZA (1) ZA825515B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2539741A1 (fr) * 1983-01-21 1984-07-27 Sanofi Sa Composes a noyau heterocyclique diazote, leur procede de preparation et les medicaments, actifs sur le systeme nerveux central, qui en contiennent
US5001125A (en) * 1984-03-26 1991-03-19 Janssen Pharmaceutica N.V. Anti-virally active pyridazinamines
JPS60218377A (ja) * 1984-04-16 1985-11-01 Mitsubishi Yuka Yakuhin Kk ４−フエニルフタラジン誘導体及びそれを有効成分とする循環改善剤
DE3664772D1 (en) * 1985-01-14 1989-09-07 Boehringer Ingelheim Kg 12-amino pyridazinoû4',5':3,4¨pyrroloû2,1-a¨isoquinolines, process for their preparation and use
US5106973A (en) * 1987-11-23 1992-04-21 Janssen Pharmaceutica N.V. Pyridzainamine derivatives
DK0628550T3 (da) 1993-06-08 1998-09-28 Vertex Pharma Pyridazin som interleukin-1 beta-omdannede enzyminhibitorer
WO2008109437A2 (en) * 2007-03-02 2008-09-12 Northwestern University Compositions and treatments for seizure-related disorders
US20100210590A1 (en) * 1995-09-27 2010-08-19 Northwestern University Compositions and treatments for seizure-related disorders
GB9707693D0 (en) * 1997-04-16 1997-06-04 Smithkline Beecham Plc Novel method of treatment
US20030176437A1 (en) * 2001-08-31 2003-09-18 D.M. Watterson Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death
ATE523199T1 (de) * 2004-11-02 2011-09-15 Univ Northwestern Pyridazinverbindungen und verfahren
BRPI0517947A (pt) 2004-11-02 2008-10-21 Univ Northwestern composto de piridazina, composições e métodos
US20100168120A1 (en) * 2006-04-28 2010-07-01 Neuromedix Inc. Salts of pyridazine compounds
JP2009535344A (ja) 2006-04-28 2009-10-01 ノースウェスタン ユニバーシティ 神経炎症性疾患の処置のためのピリダジン化合物を含む処方物
CA2650711A1 (en) * 2006-04-28 2007-11-08 Northwestern University Compositions and treatments using pyridazine compounds and cholinesterase inhibitors
WO2024148148A1 (en) * 2023-01-04 2024-07-11 The Trustees Of Columbia University In The City Of New York Pyridazine based small molecule inhibitor of cognitive impairment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1345880A (en) * 1971-06-18 1974-02-06 Cepbepe Pyridazine derivatives
FR2473522A1 (fr) * 1980-01-16 1981-07-17 Synthelabo Nouveaux derives substitues de dihydro-2,3 imidazo(1,2-b)pyridazines et les medicaments, utiles notamment comme antidepresseurs, qui en contiennent

Also Published As

Publication number Publication date
PT75372B (en) 1984-12-10
ATE23042T1 (de) 1986-11-15
JPS5838263A (ja) 1983-03-05
FI822768L (fi) 1983-02-11
CA1179347A (en) 1984-12-11
DD202550A5 (de) 1983-09-21
IL66424A0 (en) 1982-11-30
SU1356960A3 (ru) 1987-11-30
JPH0456032B2 (enExample) 1992-09-07
AU8702982A (en) 1983-05-12
US4710499A (en) 1987-12-01
DK148596B (da) 1985-08-12
GR76236B (enExample) 1984-08-04
EP0073161A1 (fr) 1983-03-02
IL66424A (en) 1985-10-31
YU171682A (en) 1985-03-20
KR840001147A (ko) 1984-03-28
FI72970C (fi) 1987-08-10
NO158871C (no) 1988-11-09
PL137200B1 (en) 1986-05-31
PL237836A1 (en) 1983-02-28
MA19559A1 (fr) 1983-04-01
ES8305736A1 (es) 1983-04-16
NZ201553A (en) 1985-08-16
PH18921A (en) 1985-11-11
IE53493B1 (en) 1988-11-23
ZA825515B (en) 1983-06-29
PT75372A (en) 1982-09-01
FR2511366B1 (enExample) 1984-12-14
KR880002711B1 (ko) 1988-12-26
HU189608B (en) 1986-07-28
DK148596C (da) 1986-01-13
IE821822L (en) 1983-02-11
FI72970B (fi) 1987-04-30
CS239929B2 (en) 1986-01-16
EP0073161B1 (fr) 1986-10-22
NO822717L (no) 1983-02-14
FI822768A0 (fi) 1982-08-09
AR231537A1 (es) 1984-12-28
AU579570B2 (en) 1988-12-01
EG15749A (en) 1986-09-30
OA07179A (fr) 1984-04-30
ES514887A0 (es) 1983-04-16
FR2511366A1 (fr) 1983-02-18
NO158871B (no) 1988-08-01
DK358782A (da) 1983-02-12

Similar Documents

Publication Publication Date Title
AU561101B2 (en) Communicating system
AU548931B2 (en) Amino pyridazines active on the central nervous system
SG93690G (en) Pyridazine derivatives active on the central nervous system,preparation process and medicines containing them
AU547661B2 (en) Steering system
AU579570B2 (en) New derivatives of pyridazine active on the central nervous system
AU546278B2 (en) Spectroanalytical system
AU574201B2 (en) Telemetry system
GB2110893B (en) Controlled-phase system
AU8214782A (en) Self restoring pivoting means
AU543733B2 (en) Active equalizer
AU9057982A (en) Locking assemblies
AU9154182A (en) Mls system
AU544688B2 (en) Support system
AU554404B2 (en) Spraying system
GB8425489D0 (en) Microlithographical system
GB2134659B (en) Gear-indicating system
AU556083B2 (en) Telemetry system
AU550192B2 (en) Harrow
JPS57130198A (en) Tracking system
CS631582A1 (en) System ovladani prumyslovych robotu s programovanym ucenim
AU8843582A (en) Activity chair
GB8500420D0 (en) Ploughing system
IE852679L (en) Pyridazines.
IE811343L (en) Azabicyclo derivatives.
PT74219B (en) Hinge-type offset wheel harrow

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee